Sugar tracker: scientists spy on immune Cells' energy use

NCT ID NCT06930976

Recruiting now Knowledge-focused Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how immune cells use glucose (sugar) for energy and building materials. Researchers will give 12 healthy adults a non-radioactive glucose tracer through an IV and then collect blood samples to track how different immune cells take up and process the sugar. The goal is purely to learn more about immune cell metabolism, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 13C6-Glucose (a non-radioactive glucose tracer given intravenously)
What this could lead to: If successful, this could reveal how immune cells use sugar for energy, potentially guiding future treatments for immune-related disorders.
What could go wrong: This is a very small, early-stage observational study (12 people) with no direct treatment goal. It is designed to gather knowledge, not to test a therapy, so it may not lead to any immediate medical advances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLUCOSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

immune system disorder metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLUCOSE IMMUNE SYSTEM AND RELATED DISORDERS ISOTOPE LABELING METABOLISM

Contacts and locations

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.